{"result": {"id": "dab491bf-9515-4104-a7a6-7eaf029d24fc", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>5-羟色胺综合征<|>event<|>5-羟色胺综合征是神经系统5-羟色胺功能亢进引起的一组可能危及生命的症状和体征，表现为自主神经功能亢进、精神状态改变和神经肌肉异常的三联征\")\n##\n(\"entity\"<|>MAOIs<|>organization<|>单胺氧化酶抑制剂类药物，与SSRIs类药物合用时需特别注意\")\n##\n(\"entity\"<|>华法林<|>organization<|>抗凝药物，与西酞普兰等SSRIs合用时需注意出血风险\")\n##\n(\"entity\"<|>TCAs<|>organization<|>三环类抗抑郁药，与氟伏沙明合用时血药浓度可能升高\")\n##\n(\"relationship\"<|>西酞普兰<|>MAOIs<|>西酞普兰注意事项中明确指出应避免与MAOIs合用<|>8)\n##\n(\"relationship\"<|>西酞普兰<|>华法林<|>西酞普兰与华法林合用时需注意出血风险<|>7)\n##\n(\"relationship\"<|>氟伏沙明<|>TCAs<|>氟伏沙明会使TCAs血药浓度升高<|>7)\n##\n(\"relationship\"<|>5-羟色胺综合征<|>SSRIs<|>5-羟色胺综合征是SSRIs类药物可能引起的严重不良反应<|>9)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558479, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 335, "prompt_tokens": 3668, "total_tokens": 4003, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 3584}, "prompt_cache_hit_tokens": 3584, "prompt_cache_miss_tokens": 84}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 汗等，往  往在服药的前几天明显，随着服药时间延长逐渐减  轻 。在最初阶段与食物同服可减少恶心的发生率， 且大多数患者描述恶心是一个短暂的不良反应 。\n\n\n常用抗抑郁药不良反应详见表 2。\n　　（3）严重不良反应：5?羟色胺综合征是神经系统  5?羟色胺功能亢进引起的一组症状和体征，有可能  危及生命。通常表现为自主神经功能亢进（发热、恶  心、腹泻、头痛、颤抖、脸红、出汗、心动过速、呼吸急  促、血压改变、瞳孔散大）、精神状态改变（轻躁狂、激  越、意识混乱、定向障碍）和神经肌肉异常（肌阵挛、 肌强直、震颤、反射亢进、踝阵挛、共济失调）的三联  征 。出现 5?羟色胺综合征时应立即停药，并根据症  状对症处理。\n\n表2    常用新型抗抑郁药使用说明［18］\n\n药名\t药理机制\t常用剂量 （mg/d）\t治疗特点\t常见不良反应\t注意事项\n西酞普兰\tSSRIs\t20~40\t对合并焦虑症状的 抑郁症有效\t恶心 、呕吐 、消化不良 、腹泻 、出汗 、 激越 、焦虑 、头痛 、失眠 、震颤 、性  功能障碍、低钠血症、皮肤出血性  疾病\n可发生撤药症状\t1. 早饭后服用；\n2. 定期查电解质、凝血功能；\n3. 避免与 MAOIs 合用；\n4. 与华法林合用时注意出血风险；\n5. 可在短期内合并镇静催眠类药物\n艾司西酞普兰\tSSRIs\t10~20\t同西酞普兰；疗效 和耐受性相对更 为平衡\t同西酞普兰\t同西酞普兰\n氟西汀\tSSRIs\t20~60\t轻度抑制食欲，很 少引起体重增加\t　同西酞普兰，失眠和激越可能更多 可改变胰岛素需要量\t1. 同西酞普兰；\n2. 与苯二氮草类药物、卡马西平合用 时后者血药浓度升高\n帕罗西汀\tSSRIs\t20~50\t治疗伴有焦虑症状 的抑郁症更有优 势\t同西酞普兰，但抗胆碱能和镇静作 用更常见；撤药反应常见\t1. 同西酞普兰；\n2. 老年人慎用；\n3. 缓慢停药\n氟伏沙明\tSSRIs\t100~300\t对睡眠有一定改善\t同西酞普兰，恶心更常见\t合用时使茶碱 、氨茶碱 、普萘洛尔 、 华法林 、咖啡因 、苯二氮草类药  物 、卡马西平 、氯氮平 、美沙酮 、 TCAs 浓度升高\n舍曲林\tSSRIs\t50~200\t改善认知功能；疗 效和耐受性相对 更为平衡\t同西酞普\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>西酞普兰<|>organization<|>西酞普兰是一种SSRIs类抗抑郁药，常用剂量为20~40mg/d，对合并焦虑症状的抑郁症有效，常见不良反应包括恶心、呕吐、消化不良等，注意事项包括早饭后服用、定期查电解质和凝血功能等)\n##\n(\"entity\"<|>艾司西酞普兰<|>organization<|>艾司西酞普兰是一种SSRIs类抗抑郁药，常用剂量为10~20mg/d，疗效和耐受性相对更为平衡，不良反应与西酞普兰类似)\n##\n(\"entity\"<|>氟西汀<|>organization<|>氟西汀是一种SSRIs类抗抑郁药，常用剂量为20~60mg/d，轻度抑制食欲，很少引起体重增加，不良反应与西酞普兰类似，但失眠和激越可能更多)\n##\n(\"entity\"<|>帕罗西汀<|>organization<|>帕罗西汀是一种SSRIs类抗抑郁药，常用剂量为20~50mg/d，治疗伴有焦虑症状的抑郁症更有优势，不良反应与西酞普兰类似，但抗胆碱能和镇静作用更常见)\n##\n(\"entity\"<|>氟伏沙明<|>organization<|>氟伏沙明是一种SSRIs类抗抑郁药，常用剂量为100~300mg/d，对睡眠有一定改善，不良反应与西酞普兰类似，但恶心更常见)\n##\n(\"entity\"<|>舍曲林<|>organization<|>舍曲林是一种SSRIs类抗抑郁药，常用剂量为50~200mg/d，改善认知功能，疗效和耐受性相对更为平衡，不良反应与西酞普兰类似)\n##\n(\"relationship\"<|>西酞普兰<|>艾司西酞普兰<|>西酞普兰和艾司西酞普兰都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>西酞普兰<|>氟西汀<|>西酞普兰和氟西汀都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>西酞普兰<|>帕罗西汀<|>西酞普兰和帕罗西汀都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>西酞普兰<|>氟伏沙明<|>西酞普兰和氟伏沙明都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>西酞普兰<|>舍曲林<|>西酞普兰和舍曲林都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>艾司西酞普兰<|>氟西汀<|>艾司西酞普兰和氟西汀都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>艾司西酞普兰<|>帕罗西汀<|>艾司西酞普兰和帕罗西汀都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>艾司西酞普兰<|>氟伏沙明<|>艾司西酞普兰和氟伏沙明都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>艾司西酞普兰<|>舍曲林<|>艾司西酞普兰和舍曲林都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>氟西汀<|>帕罗西汀<|>氟西汀和帕罗西汀都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>氟西汀<|>氟伏沙明<|>氟西汀和氟伏沙明都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>氟西汀<|>舍曲林<|>氟西汀和舍曲林都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>帕罗西汀<|>氟伏沙明<|>帕罗西汀和氟伏沙明都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>帕罗西汀<|>舍曲林<|>帕罗西汀和舍曲林都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n##\n(\"relationship\"<|>氟伏沙明<|>舍曲林<|>氟伏沙明和舍曲林都是SSRIs类抗抑郁药，具有相似的药理机制和不良反应<|>7)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_5f7e3b3e9abb89cebf235374393255bd5ec34045eae13e7d3b4a545f33b411ce_v2"}